Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia

Source:

McFadden, Rachel MPH, BSN, RN; Wallace-Keeshen, Sara FNP-BC; Petrillo Straub, Kristi AGNP-C; Hosey, Rebecca A. MPH, BSN, RN; Neuschatz, Rachel MSN, RN; McNulty, Keara BSN, RN; Thakrar, Ashish P. MD, MS. Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia. Journal of Addiction Medicine 18(1):p 9-12, 1/2 2024. | DOI: 10.1097/ADM.0000000000001245

Abstract

The veterinary sedative xylazine is spreading in unregulated opioid supplies across North America. Among people who use drugs with repeated exposure to xylazine, a distinct wound type has emerged. Here, we describe these wounds and share our experience treating them in a nurse-led, low-barrier wound care clinic in Philadelphia, PA. We propose a reimagining of wound treatment across settings to better serve people who use drugs, and we advocate for stronger protections against the harms of an increasingly adulterated drug supply. Our perspective from the epicenter of the xylazine crisis can inform the response of communities across the country who are starting to face harms associated with xylazine.